Skip to main content
Terug
Watch Compare

BIOVIE INC.

Datakwaliteit: 83%
Ook genoteerd als BIVIW NASDAQ
BIVI
NASDAQ Manufacturing Chemicals
€ 1,46
▲ € 0,05 (3,55%)
6 months return
—
Momentum
Neutral
ROE
-74,68%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-74,68%
Onder sectorgemiddelde (-54,47%)
ROIC-64,36%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio7,25
Interest Coverage-2287,35

Waardering

PE (TTM)
-0,62
Boven sectorgemiddelde (-1,50)
P/B Ratio0,53
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -14,32 M

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate
Q42024 Q12025 Q22025 Q32025
Reported -€ 4,60 -€ 1,50 -€ 11,05 -€ 0,98
Estimate — -€ 3,20 -€ 3,60 -€ 0,79
Verrassing — +53,13% -206,94% -24,05%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -74,68% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -16,50 M
ROE -74,68% ROA -66,90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -14,32 M
ROIC -64,36% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 7,25
Debt / Equity N/A Current Ratio 7,25
Interest Coverage -2287,35 Asset Turnover N/A
Working Capital 18,79 M Tangible Book Value 18,86 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,62 · EV/EBITDA: N/A
P/E Ratio -0,62 Forward P/E N/A
P/B Ratio 0,53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -140,69%
Market Cap 10,18 M Enterprise Value -10,36 M

Per Share

EPS: -12,77 · FCF/Share: -1,90
EPS (Diluted TTM) -12,77 Revenue / Share N/A
FCF / Share -1,90 OCF / Share -1,90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86,81% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 86,81%
SBC-Adj. FCF -15,41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -17,54 M -32,12 M -50,26 M -26,08 M -130,25 M
EPS (Diluted) -12,12 -7,30 -1,55 -1,06 -14,82
Gross Profit — — — — —
Operating Income -18,07 M -32,18 M -45,08 M -27,25 M -138,05 M
EBITDA — — — — —
R&D Expenses 9,27 M 23,10 M 33,30 M 17,26 M 133,19 M
SG&A Expenses 8,57 M 8,85 M 11,55 M 9,77 M 4,64 M
D&A — — — — —
Interest Expense 312.000,0 2,89 M 4,30 M 2,16 M 559.455,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21,56 M 25,21 M 35,10 M 20,11 M 6,05 M
Total Liabilities 2,55 M 9,70 M 19,76 M 16,44 M 996.374,0
Shareholders' Equity 19,01 M 15,51 M 15,34 M 3,67 M 5,05 M
Total Debt — — — — 62.500,0
Cash & Equivalents 17,54 M 23,84 M 19,46 M — —
Current Assets 20,70 M 24,05 M 34,04 M 18,78 M 4,61 M
Current Liabilities 2,27 M 9,35 M 14,49 M 4,17 M 996.374,0

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -0,6 -1,5
P/B 0,5 1,6
ROE % -74,7 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3